Should I Buy QIPT? QIPT 2026 Analysis

Should You Buy Quipt Home Medical Corp (QIPT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

3.580

1 Day change

52 Week Range

3.610

Analysis Updated At

2026/01/26

Quipt Home Medical Corp (QIPT) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently trading at $3.58 in pre-market, which is close to its updated price target of $3.65. The company's financial performance shows growth in revenue and gross margin, and the technical indicators suggest a bullish trend with moving averages in alignment. While there are no significant trading trends or recent news, the take-private transaction at $3.65 per share indicates a potential upside. The options data also reflects a strong call interest, which aligns with positive sentiment.

Technical Analysis

The technical indicators show a bullish trend with SMA_5 > SMA_20 > SMA_200. The RSI is neutral at 61.873, and the MACD histogram is negative but contracting. Key support and resistance levels are Pivot: 3.579, R1: 3.602, S1: 3.556, R2: 3.616, S2: 3.542.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Take-private transaction at $3.65 per share by Kingswood Capital Management and Forager Capital Management.
Revenue growth of 11.38% YoY and gross margin increase of 6.96% YoY in Q4
Analyst price target raised to $3.65.

Neutral/Negative Catalysts

Net income remains negative at -$3.55M, though it has improved YoY.
No recent news or significant insider/hedge fund activity.

Financial Performance

In Q4 2025, revenue increased by 11.38% YoY to $68.31M, net income improved by 20.75% YoY to -$3.55M, EPS remained flat at -0.07, and gross margin increased to 55.2%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Canaccord analyst Richard Close raised the price target to $3.65 from $2.30 and maintained a Hold rating. The update follows Q4 results that beat expectations and the take-private transaction announcement.

3 Analyst Rating

Wall Street analysts forecast QIPT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is 3.77 USD with a low forecast of 3.65 USD and a high forecast of 4 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

1 Sell

Hold

Current: 3.580

Low

3.65

Averages

3.77

High

Current: 3.580

Low

3.65

Averages

3.77

High

Canaccord

Richard Close

Hold

maintain

AI Analysis

2025-12-17

Reason

Canaccord

Richard Close

Price Target

AI Analysis

2025-12-17

maintain

Hold

Reason

Canaccord analyst Richard Close raised the firm's price target on Quipt Home Medical to $3.65 from $2.30 and keeps a Hold rating on the shares. The firm updated its model after they reported 4QFY'25 results that beat expectations, in addition to a takeprivate transaction at $3.65 US per share with Kingswood Capital Management and Forager Capital Management.

Canaccord

Richard Close

Hold

maintain

2025-08-19

Reason

Canaccord

Richard Close

Price Target

2025-08-19

maintain

Hold

Reason

Canaccord analyst Richard Close raised the firm's price target on Quipt Home Medical (QIPT) to $2.30 from $1.70 and keeps a Hold rating on the shares. The firm said they demonstrated improvement in 3Q with a sequential uptick across metrics, though it remains down year over year as the company works through some headwinds such as its Humana MA (HUM) capitated contract and disposable supply contract non-renewal.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for QIPT

Unlock Now

QIPT Should I Buy

QIPT Should I Buy

Should You Buy Quipt Home Medical Corp (QIPT) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch